Clinical trial
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal…
NCT00087191 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00087191 |
|---|---|
| Title | EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer |
| Official title | Distribution Of The Photosensitizer Motexafin Lutetium And Hypoxia In Patients With Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Fallopian Tube Cancer, Gastrointestinal Stromal Tumor, Localized Extrahepatic Bile Duct Cancer, Localized Gallbladder Cancer, Localized Gastrointestinal Carcinoid Tumor, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Metastatic Gastrointestinal Carcinoid Tumor and 61 more |
| Intervention type | Drug, Other |
| Interventions | EF5, motexafin lutetium, pharmacological study |
| Enrollment | 30 |
| Start date | May 1, 2004 |
| Primary completion | Jan 1, 2006 |
| First posted | Jul 12, 2004 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: